Aesica, a UK-based contract development and manufacturing organisation (CDMO), has appointed Ian Muir to the newly created position of Commercial Managing Director. He takes up the role on 24 February and will also join the Aesica board. The position is reflective of the company’s plans for further global expansion and has international responsibility for all aspects of the commercial business.
Muir’s responsibilities cross all three of the company’s service offerings in API manufacture, formulation development and formulated products and he will lead the expansion of the business into new growth markets such as China and Japan.
Under the new structure, Business Development, Sales and Marketing, Key Account and Product Management across Aesica will report to Muir, who will be based at the company’s headquarters in Newcastle-upon-Tyne.
Muir has more than 20 years’ experience in the pharmaceutical industry. His most recent role was at Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms. He has significant commercial experience in contract manufacturing roles for large pharmaceutical companies located in Europe, the US and Australia and has been responsible for leading both R&D activities and commercial manufacturing operations.
